Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.
BACKGROUND
Atrial electrical remodeling has been shown to influence the outcome the outcome following cardioversion of atrial fibrillation (AF) in experimental studies. The aim of the present study was to find out whether a non-invasively measured atrial fibrillatory cycle length, alone or in combination with other non-invasive parameters, could predict sinus rhythm maintenance after cardioversion of AF.


METHODS
Dominant atrial cycle length (DACL), a previously validated non-invasive index of atrial refractoriness, was measured from lead V1 and a unipolar oesophageal lead prior to cardioversion in 37 patients with persistent AF undergoing their first cardioversion.


RESULTS
32 patients were successfully cardioverted to sinus rhythm. The mean DACL in the 22 patients who suffered recurrence of AF within 6 weeks was 152 +/- 15 ms (V1) and 147 +/- 14 ms (oesophagus) compared to 155 +/- 17 ms (V1) and 151 +/- 18 ms (oesophagus) in those maintaining sinus rhythm (NS). Left atrial diameter was 48 +/- 4 mm and 44 +/- 7 mm respectively (NS). The optimal parameter predicting maintenance of sinus rhythm after 6 weeks appeared to be the ratio of the lowest dominant atrial cycle length (oesophageal lead or V1) to left atrial diameter. This ratio was significantly higher in patients remaining in sinus rhythm (3.4 +/- 0.6 vs. 3.1 +/- 0.4 ms/mm respectively, p = 0.04).


CONCLUSIONS
In this study neither an index of atrial refractory period nor left atrial diameter alone were predictors of AF recurrence within the 6 weeks of follow-up. The ratio of the two (combining electrophysiological and anatomical measurements) only slightly improve the identification of patients at high risk of recurrence of persistent AF. Consequently, other ways to asses electrical remodeling and / or other variables besides electrical remodeling are involved in determining the outcome following cardioversion.
Department of Cardiology, Lund University Hospital, SE-221 85 Lund, Sweden. carl.meurling@skane.se
Carl J
CJ
Meurling
Anders
A
Roijer
Johan E P
JE
Waktare
Fredrik
F
Holmqvist
Carl J
CJ
Lindholm
Max P
MP
Ingemansson
Jonas
J
Carlson
Martin
M
Stridh
Leif
L
Sörnmo
S Bertil
SB
Olsson
D000368:Aged; D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000503:physiopathology / Q000628:therapy*; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012008:Recurrence; D016896:Treatment Outcome